Evaluation of Commercially Available Glucagon Receptor Antibodies and Glucagon Receptor Expression
Authors:
- Anna Billeschou BomholtABAnna Billeschou Bomholt
- Christian Dall JohansenCJChristian Dall Johansen
- Sasha A. S. KjeldsenSKSasha A. S. Kjeldsen
- Katrine Douglas GalsgaardKGKatrine Douglas Galsgaard
- Jens Bager ChristensenJCJens Bager Christensen
- Marie Winther-SoerensenMWMarie Winther-Soerensen
- Reza SerizawaRSReza Serizawa
- Mads HornumMHMads Hornum
- Esteban PorriniEPEsteban Porrini
- Jens PedersenJPJens Pedersen
- Cathrine OerskovCOCathrine Oerskov
- Lise L. GluudLGLise L. Gluud
Preprint
Abstract
Glucagon is a key regulator of numerous metabolic functions including glucose, protein and lipid metabolism, and glucagon-based therapies are explored for diabetes, fatty liver disease and obesity. Insight into tissue and cell specific expression of the glucagon receptor (GCGR) is important to understand the biology of glucagon as well as to differentiate between direct and indirect actions of glucagon. However, it has been challenging to accurately localize the GCGR in tissue due to low expression levels and lack of specific methodologies. Immunohistochemistry has frequently been used for GCGR localization, but G-protein-coupled receptors (GPCRs) targeting antibodies are notoriously unreliable. In this study, we systematically evaluated all commercially available GCGR antibodies. Initially, twelve GCGR antibodies were evaluated using HEK293 cells transfected with mouse or human GCGR cDNA. Of the twelve antibodies tested, eleven showed positive staining of GCGR protein from both species. Human liver tissue was investigated using the same GCGR antibodies. Five antibodies failed to stain human liver biopsies (despite explicit claims to the contrary from the vendors). Immunohistochemical (IHC) staining demonstrated positive staining of liver tissue from glucagon receptor knockout ( Gcgr −/− ) mice and their wild-type littermates ( Gcgr +/+ ) with only one out of the twelve available GCGR antibodies. Three antibodies were selected for further evaluation by western blotting and bands corresponding to the predicted size of the GCGR (62 kDa) were identified using two of these. Finally, a single antibody (no. 11) was selected for specific GCGR localization studies in various tissues. In mouse tissue the most intense immunostainings were found in lever, kidney, ileum, heart, and pancreas. Western blotting, performed on liver tissue from Gcgr +/+ and Gcgr −/− mice, confirmed the specificity of antibody no. 11, detecting a band at high intensity in material from Gcgr +/+ and no bands in liver tissue from Gcgr −/− mice. Staining of human kidney tissue, with antibody no. 11, showed GCGR localization to the distal tubules. Autoradiography was used as an antibody-independent approach to support the antibody-based findings, revealing specific binding in liver, pancreas, and kidney. As a final approach, RNA-sequencing and single-cell RNA (scRNA)-sequencing were implemented. RNA-sequencing confirmed GCGR presence within liver and kidney tissue. The GCGR was specifically found to be expressed in hepatocytes by scRNA-sequencing and potentially also in collecting and distal tubule cells in the kidney. Our results clearly indicate the liver and the kidneys as the primary targets of glucagon action.Keywords
All Related Versions
- Published version: Communications Biology, 5 (1), 1.
This publication has 27 references indexed in Scilit:
- Pancreatic β-cell overexpression of the glucagon receptor gene results in enhanced β-cell function and massAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Physiological Levels of Glucagon Do Not Influence Lipolysis in Abdominal Adipose Tissue as Assessed by MicrodialysisThe Journal of Clinical Endocrinology & Metabolism, 2001
- Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1Molecular and Cellular Endocrinology, 1998
- Cloning and sequence analysis of the murine glucagon receptor-encoding geneGene, 1995
- Glucagon receptor mRNA distribution in rat tissuesPeptides, 1995
- Regulation of Rat Glucagon Receptor ExpressionBiochemical and Biophysical Research Communications, 1994
- Relative quantitative analysis of glucagon receptor mRNA in rat tissuesMolecular and Cellular Endocrinology, 1994
- Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouseEndocrinology, 1994
- Effets tubulaires rénaux du glucagon chez l'hommemédecine/sciences, 1985
- Receptor‐mediated endocytosis of glucagon in isolated mouse hepatocytesThe Anatomical Record, 1984